{"nctId":"NCT04422561","briefTitle":"Prophylactic Ivermectin in COVID-19 Contacts","startDateStruct":{"date":"2020-05-31","type":"ACTUAL"},"conditions":["COVID"],"count":340,"armGroups":[{"label":"Ivermectin group","type":"EXPERIMENTAL","interventionNames":["Drug: Ivermectin Tablets"]},{"label":"Control group","type":"NO_INTERVENTION","interventionNames":[]}],"interventions":[{"name":"Ivermectin Tablets","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nfamily contact of confirmed COVID-19 case\n\nExclusion Criteria:\n\n* refuse to participate and receive the drug pregnancy or lactation known hypersensitivity to ivermectin","healthyVolunteers":true,"sex":"ALL","minimumAge":"16 Years","maximumAge":"70 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Development of Symptoms ( Fever ,Cough, Sore Throat, Myalgia,Diarrhea, Shortness of Breath)","description":"history taking and clinical examination","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15","spread":null},{"groupId":"OG001","value":"59","spread":null}]}]}]},{"type":"SECONDARY","title":"Development of COVID","description":"by swab","paramType":null,"dispersionType":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":203},"commonTop":["diarrhea","nausea","fatigue","burning sensation","tingling/numbness"]}}}